CRISPRactivation-SMS, a message for PAM sequence independent gene up-regulation in Escherichia coli.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
14 10 2022
Historique:
accepted: 08 09 2022
revised: 10 08 2022
received: 04 07 2022
pubmed: 23 9 2022
medline: 18 10 2022
entrez: 22 9 2022
Statut: ppublish

Résumé

Governance of the endogenous gene regulatory network enables the navigation of cells towards beneficial traits for recombinant protein production. CRISPRactivation and interference provides the basis for gene expression modulation but is primarily applied in eukaryotes. Particularly the lack of wide-ranging prokaryotic CRISPRa studies might be attributed to intrinsic limitations of bacterial activators and Cas9 proteins. While bacterial activators need accurate spatial orientation and distancing towards the target promoter to be functional, Cas9-based CRISPR tools only bind sites adjacent to NGG PAM sequences. These circumstances hampered Cas9-guided activators from mediating the up-regulation of endogenous genes at precise positions in bacteria. We could overcome this limitation by combining the PAM independent Cas9 variant SpRY and a CRISPRa construct using phage protein MCP fused to transcriptional activator SoxS. This CRISPRa construct, referred to as SMS, was compared with previously reported CRISPRa constructs and showed up-regulation of a reporter gene library independent of its PAM sequence in Escherichia coli. We also demonstrated down-regulation and multi-gene expression control with SMS at non-NGG PAM sites. Furthermore, we successfully applied SMS to up-regulate endogenous genes, and transgenes at non-NGG PAM sites, which was impossible with the previous CRISPRa construct.

Identifiants

pubmed: 36134715
pii: 6711140
doi: 10.1093/nar/gkac804
pmc: PMC9561276
doi:

Substances chimiques

RNA, Guide 0
Recombinant Proteins 0
CRISPR-Associated Protein 9 EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10772-10784

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nat Methods. 2013 Oct;10(10):973-6
pubmed: 23892895
J Ind Microbiol Biotechnol. 2011 Dec;38(12):1891-910
pubmed: 21901404
Nat Commun. 2021 Nov 25;12(1):6916
pubmed: 34824292
Biotechnol J. 2019 Nov;14(11):e1800637
pubmed: 31231932
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Mol Biol. 2004 Oct 22;343(3):513-32
pubmed: 15465042
Nat Commun. 2019 Aug 26;10(1):3693
pubmed: 31451697
Adv Biochem Eng Biotechnol. 2004;89:73-92
pubmed: 15217156
Cell Syst. 2022 Mar 16;13(3):215-229.e8
pubmed: 34800362
CRISPR J. 2020 Oct;3(5):350-364
pubmed: 33095045
J Mol Biol. 2005 Oct 28;353(3):497-506
pubmed: 16185714
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Mol Syst Biol. 2020 Jul;16(7):e9427
pubmed: 32657546
Antimicrob Agents Chemother. 2012 Dec;56(12):6256-66
pubmed: 23006750
Microb Cell Fact. 2020 Dec 11;19(1):227
pubmed: 33308214
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
Nat Commun. 2021 Mar 5;12(1):1475
pubmed: 33674569
Front Microbiol. 2021 Jun 21;12:682001
pubmed: 34234760
Mol Microbiol. 1999 Nov;34(3):414-30
pubmed: 10564484
Nat Biotechnol. 2015 Feb;33(2):187-197
pubmed: 25513782
Nat Biotechnol. 2013 Mar;31(3):233-9
pubmed: 23360965
FEMS Microbiol Lett. 2007 Aug;273(2):187-95
pubmed: 17561947
Cell. 2015 Jan 15;160(1-2):339-50
pubmed: 25533786
Nucleic Acids Res. 2022 Jul 22;50(13):7751-7760
pubmed: 35801861
Nat Commun. 2021 Feb 8;12(1):851
pubmed: 33558474
Nat Protoc. 2007;2(10):2632-9
pubmed: 17948006
Nucleic Acids Res. 2013 Aug;41(15):7429-37
pubmed: 23761437
Bioessays. 2020 Jun;42(6):e1900252
pubmed: 32310310
Microbiol Mol Biol Rev. 1998 Jun;62(2):434-64
pubmed: 9618448
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
J Mol Biol. 2010 Aug 6;401(1):13-32
pubmed: 20595001
Nat Commun. 2020 Apr 1;11(1):1618
pubmed: 32238808
Metab Eng. 2021 Jul;66:283-295
pubmed: 33930546
Science. 2020 Apr 17;368(6488):290-296
pubmed: 32217751
J Mol Biol. 2003 Jan 31;325(5):827-41
pubmed: 12527294
Mol Syst Biol. 2014 Nov 24;10:763
pubmed: 25422271
Front Mol Biosci. 2021 May 11;8:678697
pubmed: 34046432
Nat Commun. 2021 Jan 22;12(1):555
pubmed: 33483498
Annu Rev Biophys. 2017 May 22;46:505-529
pubmed: 28375731
Nucleic Acids Res. 2021 May 7;49(8):4793-4802
pubmed: 33823546
Microb Cell Fact. 2016 Dec 19;15(1):211
pubmed: 27993152
BMC Biotechnol. 2011 Sep 23;11:87
pubmed: 21943395
Nucleic Acids Res. 1990 Nov 11;18(21):6325-30
pubmed: 2173826
Appl Environ Microbiol. 1998 May;64(5):1694-9
pubmed: 9572938
J Biol Chem. 1994 Jul 15;269(28):18371-7
pubmed: 8034583
FEMS Microbiol Rev. 2019 May 1;43(3):304-339
pubmed: 30721976
Nature. 2018 Apr 5;556(7699):57-63
pubmed: 29512652
Elife. 2019 May 29;8:
pubmed: 31140975
Genome Res. 2003 Feb;13(2):216-23
pubmed: 12566399
Nat Protoc. 2017 Apr;12(4):828-863
pubmed: 28333914
Int J Mol Sci. 2020 Apr 25;21(9):
pubmed: 32344896
Cell. 2014 Oct 23;159(3):635-46
pubmed: 25307933
Cell. 2013 Feb 28;152(5):1173-83
pubmed: 23452860
Curr Opin Biotechnol. 2020 Aug;64:190-198
pubmed: 32599515
Mol Microbiol. 2000 Aug;37(3):492-500
pubmed: 10931343
Nat Plants. 2021 Jul;7(7):942-953
pubmed: 34168320
Nucleic Acids Res. 2019 Apr 23;47(7):e40
pubmed: 30767015
Microb Cell Fact. 2020 Jul 23;19(1):148
pubmed: 32703203
ACS Synth Biol. 2018 Apr 20;7(4):1085-1094
pubmed: 29544049
J Mol Biol. 2002 Nov 15;324(1):17-34
pubmed: 12421556
PLoS Biol. 2019 Oct 11;17(10):e3000496
pubmed: 31603896
Mol Biosyst. 2012 Feb;8(2):615-28
pubmed: 22134216
Cell. 1990 Aug 24;62(4):733-43
pubmed: 2167178
Springerplus. 2015 Sep 11;4:490
pubmed: 26380166
J Bacteriol. 2016 Dec 28;199(2):
pubmed: 27799328
Nat Commun. 2018 Jun 27;9(1):2489
pubmed: 29950558
Plasmid. 2012 Mar;67(2):167-73
pubmed: 22305922
Nucleic Acids Res. 2021 Sep 7;49(15):8785-8795
pubmed: 34133740
Front Microbiol. 2020 May 05;11:828
pubmed: 32431683
BMC Biotechnol. 2020 May 11;20(1):24
pubmed: 32393331
Nat Biotechnol. 2013 Sep;31(9):833-8
pubmed: 23907171
Adv Biochem Eng Biotechnol. 2004;86:47-82
pubmed: 15088763
mBio. 2021 Oct 26;12(5):e0213021
pubmed: 34607455
J Mol Biol. 2011 Apr 1;407(3):333-53
pubmed: 21195716
J Biotechnol. 2008 May 20;135(1):34-44
pubmed: 18405993
Microbiol Mol Biol Rev. 1997 Dec;61(4):393-410
pubmed: 9409145

Auteurs

Marco Klanschnig (M)

Christian Doppler Laboratory for Production of Next-Level Biopharmaceuticals in E. coli, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, 1190 Vienna, Austria.

Monika Cserjan-Puschmann (M)

Christian Doppler Laboratory for Production of Next-Level Biopharmaceuticals in E. coli, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, 1190 Vienna, Austria.

Gerald Striedner (G)

Christian Doppler Laboratory for Production of Next-Level Biopharmaceuticals in E. coli, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, 1190 Vienna, Austria.

Reingard Grabherr (R)

Christian Doppler Laboratory for Production of Next-Level Biopharmaceuticals in E. coli, Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, 1190 Vienna, Austria.

Articles similaires

Prader-Willi Syndrome Humans Angelman Syndrome CRISPR-Cas Systems Human Embryonic Stem Cells
Female Biofilms Animals Lactobacillus Mice
Host Specificity Bacteriophages Genomics Algorithms Escherichia coli
Humans Pulmonary Disease, Chronic Obstructive RNA, Long Noncoding Male Female

Classifications MeSH